Goals of ICare's
survival rates through better patient/physician
awareness of options
use of state-of-the-art therapies, including those
in clinical trials, that promise fewer harmful
side-effects, greater effectiveness
- Decrease time
required to move promising therapies out of the lab
and to the patient.
ICare's Targeted Information Programs (TIPs)
Click through to targeted information.
ICARE Clinical Trial Matching Program
ICare is committed to informing each
patient, and their doctor, about every available
resource, including new therapies recently approved by
FDA clinical trials that are in progress and those
trials that are about to begin recruiting.
ICARE currently disseminates clinical trial
information through its Think Tanks and symposium, both
of which include patients as full participants, along
with top doctors and cancer scientists.
Our Clinical Trial Matching Program
under development seeks to build new two-way bridges
among all stakeholders (patients, doctors, drug
researchers and FDA officials) and will allow all
participants to take a more active role in the planning,
promoting and evaluating the clinical trial process.